MARKET

NMRA

NMRA

Neumora Therapeutics Inc
NASDAQ
2.290
+0.470
+25.82%
Pre Market: 2.290 0 0.00% 05:09 01/08 EST
OPEN
2.080
PREV CLOSE
1.820
HIGH
2.540
LOW
2.050
VOLUME
580
TURNOVER
0
52 WEEK HIGH
3.250
52 WEEK LOW
0.6110
MARKET CAP
389.16M
P/E (TTM)
-1.5651
1D
5D
1M
3M
1Y
5Y
1D
Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday
Benzinga · 20h ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 23h ago
Neumora Therapeutics price target raised to $6 from $5 at Mizuho
TipRanks · 1d ago
J.P. Morgan Remains a Sell on Neumora Therapeutics, Inc. (NMRA)
TipRanks · 1d ago
NEUMORA THERAPEUTICS INC <NMRA.O>: MIZUHO RAISES TARGET PRICE TO $6 FROM $5
Reuters · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Qualcomm, Costco, Topgolf Callaway Brands
Reuters · 2d ago
Neumora's Alzheimer's Agitation Drug Shows Early Promise
Benzinga · 2d ago
Analysts Are Bullish on These Healthcare Stocks: Fortrea Holdings Inc. (FTRE), DENTSPLY SIRONA (XRAY)
TipRanks · 2d ago
More
About NMRA
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Navacaprant is being investigated in the KOASTAL pivotal Phase 3 program, evaluating navacaprant monotherapy in patients with moderate to severe MDD. The Company's next advanced product candidate is NMRA-511, which is a highly selective, novel antagonist of the vasopressin 1a receptor (V1aR) being developed for the treatment of agitation associated with dementia due to Alzheimer's disease (AD).

Webull offers Neumora Therapeutics Inc stock information, including NASDAQ: NMRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NMRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NMRA stock methods without spending real money on the virtual paper trading platform.